[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quanterix Corp (QTRX)

Quanterix Corp (QTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 182,065
  • Shares Outstanding, K 47,106
  • Annual Sales, $ 138,900 K
  • Annual Income, $ -107,150 K
  • EBIT $ -141 M
  • EBITDA $ -117 M
  • 60-Month Beta 1.04
  • Price/Sales 1.34
  • Price/Cash Flow N/A
  • Price/Book 0.66

Options Overview Details

View History
  • Implied Volatility 128.14% (-19.72%)
  • Historical Volatility 105.79%
  • IV Percentile 35%
  • IV Rank 15.72%
  • IV High 472.23% on 03/30/26
  • IV Low 63.94% on 08/18/25
  • Expected Move (DTE 33) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 51
  • Volume Avg (30-Day) 262
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 6,010
  • Open Int (30-Day) 4,408
  • Expected Range 3.87 to 3.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.47
  • Growth Rate Est. (year over year) +212,653.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.95 +31.02%
on 06/18/26
4.57 -15.43%
on 06/29/26
+0.98 (+34.20%)
since 06/17/26
3-Month
2.39 +61.38%
on 05/19/26
4.57 -15.43%
on 06/29/26
+0.37 (+10.43%)
since 04/17/26
52-Week
2.39 +61.38%
on 05/19/26
8.77 -55.93%
on 01/09/26
-1.65 (-29.85%)
since 07/17/25

Most Recent Stories

More News
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that on July 15, 2026, an inducement grant (the “Inducement...

QTRX : 3.87 (-2.40%)
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages

Beginning July 1, 2026, Anthem Blue Cross and Blue Shield medical policies support eligible blood-based biomarker testing New peer-reviewed and AAIC data reinforce the...

QTRX : 3.87 (-2.40%)
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that...

QTRX : 3.87 (-2.40%)
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler...

QTRX : 3.87 (-2.40%)
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics

Strategic Leadership Addition Signals Drive to Expand Diagnostics Business

QTRX : 3.87 (-2.40%)
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that senior management will participate...

QTRX : 3.87 (-2.40%)
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that...

QTRX : 3.87 (-2.40%)
Quanterix Announces Planned Transition of Chief Financial Officer

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial...

QTRX : 3.87 (-2.40%)
Quanterix Releases Financial Results for the First Quarter of 2026

Reports $36.4 million in revenue and approximately $103 million of cash and marketable securities Company prioritizing product roadmap and investing in initiatives to...

QTRX : 3.87 (-2.40%)
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows

Agreement supports the identification of patients eligible for Alzheimer’s disease biomarker testing through Tempus Next and enables neurologists to order LucentAD® Complete on Tempus’ clinical ordering...

TEM : 52.47 (-2.09%)
QTRX : 3.87 (-2.40%)

Business Summary

Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa...

See More

Key Turning Points

3rd Resistance Point 4.48
2nd Resistance Point 4.32
1st Resistance Point 4.09
Last Price 3.87
1st Support Level 3.70
2nd Support Level 3.53
3rd Support Level 3.31

See More

52-Week High 8.77
Fibonacci 61.8% 6.33
Fibonacci 50% 5.58
Fibonacci 38.2% 4.83
Last Price 3.87
52-Week Low 2.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.